It is very uncertain whether single‐dose fosfomycin changes persistent bacteriuria compared with single‐dose netilmicin (very low certainty).
It is very uncertain whether single‐dose fosfomycin changes recurrence compared with single‐dose netilmicin (very low certainty).
Albendazole single dose showed no clear difference in parasitological cure compared with ivermectin single dose cure rate (moderate certainty).
Albendazole 400 mg single dose showed no clear difference in parasitological cure compared with mebendazole 500 mg single dose (high certainty).
It is very uncertain whether praziquantel 40 mg/kg single dose changes haematuria compared with 30 mg/kg single dose (very low certainty).
It is very uncertain whether praziquantel 40 mg/kg single dose changes proteinuria compared with 30 mg/kg single dose (very low certainty).
Praziquantel 40 mg/kg single dose may leads to lower parasitological failure At 1 month compared with 30 mg/kg single dose (low certainty).
Praziquantel 40 mg/kg single dose showed no clear difference in parasitological failure At 6 months compared with 30 mg/kg single dose (moderate certainty).
Single‐dose, preoperative MMC‐EMDA probably leads to lower time to recurrence compared with single‐dose, postoperative MMC‐PD (moderate certainty).
It is very uncertain whether single‐dose, preoperative MMC‐EMDA changes time to progression compared with single‐dose, postoperative MMC‐PD (very low certainty).
It is very uncertain whether single‐dose, preoperative MMC‐EMDA changes serious adverse events compared with single‐dose, postoperative MMC‐PD (very low certainty).
Single‐dose, preoperative MMC‐EMDA showed no clear difference in disease‐specific survival compared with single‐dose, postoperative MMC‐PD (low certainty).